We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.73B
AUM Growth
+$122M
Cap. Flow
-$305M
Cap. Flow %
-5.31%
Top 10 Hldgs %
36.62%
Holding
266
New
17
Increased
50
Reduced
179
Closed
19

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$54.5M
2
NVO
Novo Nordisk
NVO
+$53.8M
3
ABNB icon
Airbnb
ABNB
+$35.5M
4
BNTX icon
BioNTech
BNTX
+$22.3M
5
NVDA icon
NVIDIA
NVDA
+$16.9M

Sector Composition

Rank Sector Weight
1 Technology 32.17%
2 Consumer Discretionary 24.08%
3 Healthcare 19.02%
4 Industrials 8.18%
5 Communication Services 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMBA icon
226
Ambarella
AMBA
$2.91B
$419K 0.01%
7,465
-2,198
-23% -$163K
ILMN icon
227
Illumina
ILMN
$31.9B
$412K 0.01%
2,217
+14
+0.6% +$2.77K
VITL icon
228
Vital Farms
VITL
$421M
$397K 0.01%
33,201
-144
-0.4% -$1.72K
EQRX
229
DELISTED
EQRx, Inc. Common Stock
EQRX
$396K 0.01%
80,028
-113,285
-59% -$571K
OLO
230
DELISTED
Olo Inc
OLO
$381K 0.01%
48,270
-28,638
-37% -$274K
PATH icon
231
UiPath
PATH
$7.58B
$378K 0.01%
29,949
-25
-0.1% -$438
ENFN
232
DELISTED
Enfusion, Inc.
ENFN
$355K 0.01%
28,774
+692
+2% +$8.44K
EWCZ
233
DELISTED
European Wax Center
EWCZ
$331K 0.01%
17,950
+3,359
+23% +$66.1K
FTHM icon
234
Fathom Holdings
FTHM
$19.6M
$293K 0.01%
55,200
-303,807
-85% -$2.05M
SHEN icon
235
Shenandoah Telecom
SHEN
$649M
$292K 0.01%
17,142
+335
+2% +$7.14K
SLDP icon
236
Solid Power
SLDP
$554M
$277K ﹤0.01%
52,675
-25,204
-32% -$159K
ALEC icon
237
Alector
ALEC
$241M
$234K ﹤0.01%
24,703
-114,690
-82% -$1.24M
NEX
238
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$231K ﹤0.01%
+31,239
New +$274K
Z icon
239
Zillow
Z
$7.37B
$221K ﹤0.01%
+7,736
New +$269K
RELY icon
240
Remitly
RELY
$4.64B
$202K ﹤0.01%
18,209
-73
-0.4% -$762
CRDO icon
241
Credo Technology Group
CRDO
$28.3B
$190K ﹤0.01%
17,281
-589,220
-97% -$7.77M
CURV icon
242
Torrid Holdings
CURV
$222M
$186K ﹤0.01%
44,641
NYXH
243
Nyxoah
NYXH
$161M
$186K ﹤0.01%
29,472
-353
-1% -$3.03K
EB
244
DELISTED
Eventbrite
EB
$178K ﹤0.01%
29,301
-824
-3% -$6.94K
RDFN
245
DELISTED
Redfin
RDFN
$113K ﹤0.01%
19,266
-54,952
-74% -$488K
COMP icon
246
Compass
COMP
$8.05B
$110K ﹤0.01%
47,326
-1,507
-3% -$5.35K
PRQR icon
247
ProQR Therapeutics
PRQR
$258M
$72K ﹤0.01%
97,019
-808
-0.8% -$649
ARIS
248
DELISTED
Aris Water Solutions
ARIS
-18,395
Closed -$307K
AZEK
249
DELISTED
The AZEK Co
AZEK
-120,008
Closed -$2.01M
DLTR icon
250
Dollar Tree
DLTR
$21.9B
-2,196
Closed -$342K

Similar funds

Gilder Gagnon Howe & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Gilder Gagnon Howe & Co held 266 positions worth $5.73B, up 2.2% from $5.61B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $305M in Q3 2022, closing 19 positions and reducing 179 holdings. Its most notable exit was 1Life Healthcare, an estimated $23.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Novo Nordisk worth $50M.

  • Gilder Gagnon Howe & Co's largest Q3 2022 buy was Novo Nordisk: 1,004,430 shares worth $50M.
  • Gilder Gagnon Howe & Co added most to Eli Lilly in Q3 2022, an estimated $54.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2022 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $45.6M.
  • Gilder Gagnon Howe & Co fully exited 1Life Healthcare in Q3 2022, selling an estimated $23.4M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 37% of its $5.73B portfolio in Q3 2022.
  • Gilder Gagnon Howe & Co opened 17 new positions and closed 19 in Q3 2022.
  • Gilder Gagnon Howe & Co's portfolio value rose 2.2% quarter-over-quarter to $5.73B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2022, filed 14 Nov 2022.